Glipizide
Product Images NDC 21695-967

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 21695-967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Glipizide (289bda32 6198 4072 A9f3 283438bda707 01)

Chemical structure of Glipizide, a sulfonylurea antidiabetic agent, showing its molecular framework with aromatic rings, sulfonyl, amide, and cyclohexyl groups.*

FDA Label Image

Glipizide 2.5mg (289bda32 6198 4072 A9f3 283438bda707 02)

Label for Glipizide ER 2.5mg tablets by Physician Partner, distributed by Rebel Distributors Corp. The label states each extended-release tablet contains 2.5mg of Glipizide USP. It includes quantity (#30), product ID RG096730, and manufacturer Patheon Pharmaceuticals Inc., Cincinnati, OH. Storage instructions specify controlled room temperature 15°-30°C (59°-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.